ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $442 | -99.5% | 71,000 | +305.7% | 0.70% | +445.3% |
| Q1 2022 | $81,000 | -67.9% | 17,500 | -65.3% | 0.13% | -60.6% |
| Q4 2021 | $252,000 | -16.3% | 50,500 | +573.3% | 0.32% | +112.4% |
| Q1 2019 | $301,000 | +48.3% | 7,500 | -63.4% | 0.15% | +40.4% |
| Q2 2016 | $203,000 | -63.6% | 20,500 | -37.9% | 0.11% | -33.1% |
| Q1 2016 | $558,000 | -51.8% | 33,000 | -36.5% | 0.16% | -58.5% |
| Q4 2015 | $1,158,000 | – | 52,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |